Clinical Trial Update: Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pazopanib as pre-surgical therapy in treatment-naive non-small cell lung cancer patients; results were posted after trial completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Non-Small Cell Lung Cancer, Lung Cancer, Non-Small Cell | Phase 2 | Status: COMPLETED | Results posted: 2010-03-17